retatrutide type 2 diabetes More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide—A Game Changer in Obesity

Aug 28 2020;12(9)doi:10.3390/nu12092631 Farshidi H, Sobhani AR, Eslami M, et al

They offer: Appetite Control: By interacting with hunger-regulating hormones, these treatments help individuals feel full longer, making it easier to consume fewer calories without constant cravings

M.FidanE.YangQ.AnthonymuthuT

PD Mangan Diet A protein-heavy, longevity-driven approach to eating, complete with real meal photos showing how simple it stays

The studys limitations include the cross-sectional nature, which precludes establishing causality, self-reporting of anthropometric and demographic data, which might lead to bias, and unidentified confounding